Curanex Pharmaceuticals Inc [NASDAQ: CURX] traded at a low on 2025-09-17, posting a -83.46 loss after which it closed the day’ session at $1.51.
The market cap for CURX stock reached $42.04 million, with 27.75 million shares outstanding and 27.75 million shares in the current float. Compared to the average trading volume of 2.70M shares, CURX reached a trading volume of 25420354 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Curanex Pharmaceuticals Inc [CURX]?
The Price to Book ratio for the last quarter was 137.73, with the Price to Cash per share for the same quarter was set at 0.00.
How has CURX stock performed recently?
Curanex Pharmaceuticals Inc [CURX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -80.53.
Curanex Pharmaceuticals Inc (CURX) Capital Structure & Debt Analysis
According to recent financial data for Curanex Pharmaceuticals Inc. ( CURX), the Return on Equity (ROE) stands at -85.25%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -57.89%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Curanex Pharmaceuticals Inc’s Return on Invested Capital (ROIC) is -61.16%, showcasing its effectiveness in deploying capital for earnings.
Curanex Pharmaceuticals Inc (CURX) Efficiency & Liquidity Metrics
Based on Curanex Pharmaceuticals Inc’s (CURX) latest financial statements, the Debt-to-Equity Ratio is 1.55%, indicating its reliance on debt financing relative to shareholder equity.
